Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Are Alzheimer’s Blood Tests Living Up to the Hype?
Coffee & Alzheimer’s Disease: What’s the Verdict?
Flu Season: Here’s What Skipping the Flu Vaccine Does to Your Dementia Risk
Untreated Blood Pressure, Significantly Higher Alzheimer’s Risk
Dementia Biomarkers 101: What is Tau?
Athira’s Alzheimer’s Drug Fails in Later-stage Clinical Trial
For Patients on Discontinued Aduhelm, What Now?
Does Long COVID Lead to Alzheimer’s? A New Study Took an Unexpected Turn
Do You Have Alzheimer’s? New Diagnostic Criteria Might Change the Answer
UK Health Services Says Leqembi Is Too Costly, Too Risky to Cover
Despite New Spin, Obesity and Diabetes Drug Failed Alzheimer’s Trial
An Unexpected Way to Lower Your Dementia Risk: Pet Ownership
What Happens When Insurance Refuses to Cover Your Alzheimer’s Prescription?
AAIC: Experts Discuss the Future of Alzheimer’s Treatments
Updates on Alzheimer’s Drug Research from AAIC 2024
Previous
13
14
15
Next
Page load link
Go to Top